 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
4/25/24 Abvc Biopharma, Inc. POS AM 88:8.6M EdgarAgents LLC/FA
3/15/24‡ Abvc Biopharma, Inc. 10-K/A 12/31/23 17:451K EdgarAgents LLC/FA
1/12/24 Abvc Biopharma, Inc. S-1 113:12M EdgarAgents LLC/FA
12/29/23 Abvc Biopharma, Inc. DEF 14A 1/16/24 1:10M EdgarAgents LLC/FA
12/15/23 Abvc Biopharma, Inc. PRE 14A 12/15/23 1:10M EdgarAgents LLC/FA
6/7/23 Abvc Biopharma, Inc. S-1/A 12:235K EdgarAgents LLC/FA
5/10/23 Abvc Biopharma, Inc. S-1/A 85:8M EdgarAgents LLC/FA
4/26/23 Abvc Biopharma, Inc. POS AM 86:9M EdgarAgents LLC/FA
4/24/23 Abvc Biopharma, Inc. S-1 88:8.1M EdgarAgents LLC/FA
3/31/23 Abvc Biopharma, Inc. 10-K 12/31/22 92:8M EdgarAgents LLC/FA
6/14/22 Abvc Biopharma, Inc. POS AM 110:12M EdgarAgents LLC/FA
6/6/22 Abvc Biopharma, Inc. 10-K/A 12/31/21 15:316K EdgarAgents LLC/FA
11/16/21 Abvc Biopharma, Inc. S-3/A 2:349K EdgarAgents LLC/FA
10/29/21 Abvc Biopharma, Inc. S-3 5:1M EdgarAgents LLC/FA
4/8/21‡ Abvc Biopharma, Inc. S-1 4/7/21 2:2.5M EdgarAgents LLC/FA
| ____________ | | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | | ¹ | Filing/Form Types: | | 10-K | Annual Report — Form 10-K. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | | POS AM | Post-Effective Amendment of a Registration Statement. | | PRE 14A | Preliminary Proxy Statement — Schedule 14A. | | S-1 | Registration Statement (General Form) — Form S-1. | | S-3 | Registration Statement – Securities for a Transaction — Form S-3. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. |
|
